74 filings
8-K
MXCT
MaxCyte Inc
12 Jun 24
Departure of Directors or Certain Officers
4:45pm
10-Q
2024 Q1
MXCT
MaxCyte Inc
Quarterly report
7 May 24
5:00pm
8-K
MXCT
MaxCyte Inc
7 May 24
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance
4:14pm
ARS
2023 FY
MXCT
MaxCyte Inc
1 May 24
Annual report to shareholders
4:20pm
DEF 14A
MXCT
MaxCyte Inc
Definitive proxy
26 Apr 24
5:14pm
8-K
tng1g
12 Mar 24
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
4:10pm
8-K
f47ce0 pir
5 Mar 24
MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results
4:15pm
8-K
snyraifiqco7 dm05
26 Jan 24
Departure of Directors or Certain Officers
4:45pm
8-K
6mywv 0xkxj69vuox10
8 Jan 24
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results
4:15pm
8-K
mgawxitmrd6t7
11 Dec 23
MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023
4:30pm
8-K
h9wczdfg0wmt
8 Nov 23
MaxCyte Reports Third Quarter 2023 Financial Results and Reiterates Full Year 2023 Revenue Guidance
4:12pm
8-K
0240vgca9yv
4 Oct 23
MaxCyte Announces Preliminary Third Quarter 2023 Revenue and Updates Full Year 2023 Revenue Guidance
4:14pm
8-K
kgh sdjoe
9 Aug 23
MaxCyte Reports Second Quarter and Half-Year 2023 Financial Results and Updates Full Year 2023 Guidance
4:16pm
8-K
kopee0gjhpsa4hf pgw
23 Jun 23
Departure of Directors or Certain Officers
9:27am
8-K
0n7wieit
10 May 23
MaxCyte Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Guidance
4:14pm
ARS
c4wmz0qn14htt9
28 Apr 23
Annual report to shareholders
4:27pm